DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02509 QYUNS-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Qiu Jiwan & Associates (31.21%)
Hangzhou Quanyi Investment Management Partnership (General Partnership) (17.69%)
Huadong Medicine Co., Ltd. (16.75%)
Taizhou Medicine City Holding Group Co., Ltd. (11.72%)
Taizhou Xinfu Tongxin Enterprise Management Partnership (Limited Partnership) (6.88%)		 Sector Health Care & Biotechnology
Web Site http://www.qyuns.net Tel (86 523) 8027-6311
Email IR@qyuns.net Fax N/A
Related Equities N/A
Principal Activities Principally engaged in research and development of biologic therapies for autoimmune and allergic diseases.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top